1998
Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases. Mol Cell. 1998;2(5):571-80.
Do molecular markers predict survival in non-small-cell lung cancer? Am J Respir Crit Care Med. 1998;157(4 Pt 1):1093-7.
Pooled analysis of p53 mutations in hematological malignancies. Hum Mutat. 1998;12(1):4-18.
p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem. 1998;273(37):24057-64.
In vitro studies of the interactions between platelets and amniotic membranes: a potential treatment for preterm premature rupture of the membranes. Am J Obstet Gynecol. 1998;178(2):287-93.
Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. J Biol Chem. 1998;273(47):31480-5.
Induction by interleukin-1beta peptide of prostaglandin E2 formation via enhanced prostaglandin H synthase-2 expression in 3T6 fibroblasts. Biochem Pharmacol. 1998;56(6):759-61.